In contrast, further increasing the dose to 2 μg showed a trend of decreased effects ( Supplementary Figure S5 ).
← all excerpts
Highly efficient genome editing via CRISPR-Cas9 in human pluripotent stem cells is achieved by transient BCL-XL overexpression.
1
—
—